Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.

Masahiro Fujita1, Masanori Ichise, Sami S Zoghbi

  • 1Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 1, Room B3-10, I Center Drive, MSC-0135, Bethesda, MD, USA. fujitam@intra.nimh.nih,gov

Annals of Neurology
|December 24, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and Preclinical Evaluation of [<sup>11</sup>C]GNE-0877 as a Potential PET Radioligand for Imaging Brain Leucine-Rich Repeat Kinase 2.

ACS omega·2026
Same author

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

NPJ Parkinson's disease·2026
Same author

[<sup>11</sup>C]PS13 PET shows that age is positively correlated with constitutively expressed cyclooxygenase-1 in the brain.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP.

Translational psychiatry·2026
Same author

Corrigendum to 'Synthesis and investigation of substituted 1,5-diaryl-1H-1,2,4-triazoles for the discovery of <sup>18</sup>F-labeled probes for imaging brain cyclooxygenase-1' [Eur. J. Med. Chem. 2025, 118523].

European journal of medicinal chemistry·2026
Same author

Organ-Specific Perfusion Response to Adenosine as Measured Using Total-Body PET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.

Annals of neurology·2026
Same journal

Five Issues of Artificial Intelligence in Science: Sailing the Ship of Theseus.

Annals of neurology·2026
Same journal

Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

Annals of neurology·2026
Same journal

Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

Annals of neurology·2026
Same journal

Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

Annals of neurology·2026
Same journal

Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

Annals of neurology·2026
See all related articles
This summary is machine-generated.

Parkinson's disease is linked to a widespread 10% decrease in nicotinic acetylcholine receptors in the brain. This study compared these receptors in Parkinson's patients and healthy individuals.

Area of Science:

  • Neuroscience
  • Radiology

Background:

  • Nicotinic acetylcholine receptors are crucial for cognitive function.
  • These receptors interact closely with the brain's dopaminergic system.

Purpose of the Study:

  • To compare nicotinic acetylcholine receptor levels between living Parkinson's disease (PD) patients and healthy subjects.
  • To investigate the role of these receptors in PD.

Main Methods:

  • Single-photon emission computed tomography (SPECT) imaging was used.
  • A specific SPECT ligand, [(123)I]5-iodo-3-[2(S)-2-azetidinylmethoxy]pyridine, was employed.
  • Total distribution volume (V) and delivery (K(1)) of receptors were measured using an arterial input function.

Main Results:

  • Parkinson's disease patients exhibited a significant, widespread decrease (approximately 10%) in receptor volume (V).

Related Experiment Videos

  • This decrease was observed in both cortical and subcortical brain regions.
  • No significant change in receptor delivery (K(1)) was found.

    • Conclusions:

    • The findings highlight the significant reduction of nicotinic acetylcholine receptors in PD.
    • Further research is warranted to include demented PD patients.